- Product
- What are the latest COVID-19 drug guidelines?
- by Choi, sun Jan 8, 2021 06:19am
- As COVID-19 pandemic has passed a year, the guidelines for drug use are being updated a lot. As the evidence was accumulated, the differences in the guidelines for use by each country decreased, and detailed recommendations for practical use were derived with recommendations for use and refraining from various cases even with the same drug.
- Product
- “The lower the income, the later the cancer diagnosis”
- by Eo, Yun-Ho Dec 16, 2020 06:13am
- A survey found a clear correlation between the income level and the level of tumor development and metastasis when a patient with cancer is diagnosed. A not-for-profit organization advocating the improvement in inefficiency in cancer treatment environment, ‘All.Can Korea’ kicked off on Dec. 10 and disclosed a survey result on 495 canc
- Product
- Instructing Tamiflu users on neurological side effect
- by Kang, Shin-Kook Dec 11, 2020 06:14am
- “Have you heard of that incident two years ago, where a middle school student took a fall after taking Tamiflu?” The importance of influenza treatment administration instruction is reiterated due to the reported neurological adverse reaction after the administration. On Dec. 9, the Korean Pharmaceutical Association (KPA) notified a
- Product
- What’s it like to have ATTR-CM in Korea
- by won, jong-hyuk Dec 10, 2020 06:09am
- A few years ago, a 50-year-old man visited a hospital when he experienced shortness of breath and edema. But he had to visit a number of hospitals for years for examination as he struggled to pin point the name of the disease. And one day, he felt tingling sensation in his toes and examined the heart. That was the time he had to face his rar
- Product
- COVID-19 vaccine almost there, how about cost-effectiveness?
- by Choi,sun Dec 7, 2020 06:05am
- The anticipation for the COVID-19 vaccines in development is soaring as a number of global pharmaceutical companies have announced successful clinical trial results. The health authority and the public would closely follow the vaccines’ further development to confirm their effect, safety and reasonable pricing. ▲The COVID-19 vaccine
- Product
- High risk in bone fracture found with long-term GCs use
- by Lee, in-bok Nov 30, 2020 06:20am
- A study claims a long-term prescription of glucocorticoid (GCs) could raise the risk of osteoporosis and bone fracture even in South Koreans. The researchers found the bone density dips significantly and the risk goes up high three months into the prescription. So far, there were studies condudcted in the U.S. and Europe warning such risks,
- Product
- The amount of prescriptions for NSAIDS is increasing rapidly
- by Lee, in-bok Nov 27, 2020 06:29am
- The number of prescriptions for non-steroidal anti-inflammatory drugs (NSAIDS), which are contraindicated for hypertension, asthma patients, and pregnant women, was continuously increasing. Celecoxib took up the most prescription ingredients, and Celebrex recorded the most prescriptions. In particular, Daewon's Pelubi drew attention as it was m
- Product
- Struggling with dementia drug, Aβ-targeting drug unapproved
- by won-jong-hyuk Nov 26, 2020 06:03am
- Although many of Alzheimer's disease-targeting novel drugs are in development, the market is struggling to receive the health authority approval with troubles found during efficacy validation To this date, multinational pharmaceutical companies have initiated investigation on antibody agents targeting a number of therapeutic targets, such as
- Product
- A professor reserves thoughts on “90% effective vaccine"
- by Kim, Min-Gun Nov 16, 2020 06:02am
- A U.S. pharmaceutical company Pfizer has attracted a global attention as it announced a COVID-19 vaccine in development has demonstrated an efficacy rate above 90 percent in early results from a Phase 3 trial. One of vaccine experts in South Korea, Professor Seol Dai Wu at Chung-Ang University College of Pharmacy spoke on Nov. 11 at an
- Product
- Pfizer’s all the items expected to be out of stock?
- by Jung, Heung-Jun Nov 11, 2020 06:08am
- When some local wholesalers sent a text message to the pharmacy saying that all Pfizer items from Pfizer Korea are expected to be sold out, pharmacists are placing large orders to secure stock. The text message the pharmacy received from a wholesaler said that Pfizer stopped placing orders after sales of Pfizer this year, and accordingly,
